# OrphanCure Full Pipeline Report: repodb_0ee62470d8ffb2ae

- Drug: Cisplatin
- Disease: Esophageal neoplasm metastatic
- Mode: full
- Status: completed
- Final assessment: Potential

This generated report is for research support only and is not medical advice.

## Structured Output

```json
{
  "sections": {
    "1_executive_summary": {
      "conclusion": "Potential",
      "confidence": "High",
      "summary": "Cisplatin is a standard first-line treatment for advanced esophageal cancer, but resistance is a significant clinical challenge. Several studies explore mechanisms of cisplatin resistance and strategies to overcome it, including targeting specific miRNAs and pathways. While direct evidence for repurposing cisplatin is limited as it's already in use, research focuses on enhancing its efficacy and overcoming resistance.",
      "evidence_counts": {
        "total_papers": 60,
        "supporting": 42,
        "contradicting": 7,
        "inconclusive": 11
      },
      "common_targets_count": 0
    },
    "2_normalized_hypothesis": {
      "statement": "Repurpose CISPLATIN for esophageal cancer",
      "drug": {
        "id": "CHEMBL11359",
        "name": "CISPLATIN",
        "aliases": [
          "cis-diamminedichloroplatinum(II)",
          "CDDP",
          "cisplatin",
          "cis-DDP",
          "cis-diaminedichloroplatinum(II)"
        ],
        "resolution_method": "auto"
      },
      "disease": {
        "id": "MONDO_0007576",
        "name": "esophageal cancer",
        "aliases": [
          "cancer of the esophagus",
          "esophageal carcinoma",
          "esophageal malignancy",
          "cancer of the gullet",
          "gullet cancer"
        ],
        "resolution_method": "auto"
      }
    },
    "3_mechanistic_rationale": {
      "total_mechanisms": 0,
      "mechanisms": []
    },
    "4_target_overlap_summary": {
      "total_overlapping": 0,
      "top_targets": []
    },
    "5_literature_evidence_summary": {
      "total_retrieved": 60,
      "polarity": {
        "supports": 42,
        "contradicts": 7,
        "inconclusive": 11
      },
      "support_ratio": "42 of 60 retrieved papers support the hypothesis",
      "queries_used": 9,
      "top_papers": [
        {
          "pmid": "38494800",
          "title": "[History and Perspective of Chemotherapy in Advanced Esophageal Cancer].",
          "year": "2024",
          "relevance_score": 11.0,
          "polarity": "CONTRADICTS",
          "match_reasons": [
            "Contradiction signal",
            "Clinical study",
            "Recent"
          ]
        },
        {
          "pmid": "36995552",
          "title": "NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells.",
          "year": "2023",
          "relevance_score": 10.5,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "37672204",
          "title": "Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance.",
          "year": "2024",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "34277424",
          "title": "Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin.",
          "year": "2021",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Title Match"
          ]
        },
        {
          "pmid": "37401860",
          "title": "LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.",
          "year": "2023",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "38251697",
          "title": "Autophagy Inhibition and Sensitization to Cisplatin in Esophageal Cancer Stem-like Cells via All-trans Retinoic Acid-induced miR-30a.",
          "year": "2025",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "38418117",
          "title": "Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin.",
          "year": "2024",
          "relevance_score": 10.0,
          "polarity": "CONTRADICTS",
          "match_reasons": [
            "Contradiction signal",
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "33067427",
          "title": "Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.",
          "year": "2020",
          "relevance_score": 9.5,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Title Match"
          ]
        },
        {
          "pmid": "39934309",
          "title": "ZCCHC4 regulates esophageal cancer progression and cisplatin resistance through ROS/c-myc axis.",
          "year": "2025",
          "relevance_score": 9.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "40269355",
          "title": "Extracellular transfer of HuR promotes acquired cisplatin resistance in esophageal cancer cells.",
          "year": "2025",
          "relevance_score": 9.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        }
      ]
    },
    "6_contradictory_evidence": {
      "count": 0,
      "claims": []
    },
    "7_confidence_assessment": {
      "overall": "High",
      "dimensions": {
        "mechanistic_strength": "High",
        "literature_strength": "High",
        "clinical_evidence": "Medium"
      },
      "quality_scorecard": {
        "overall_score": 0.772,
        "decision": "finalize",
        "dimensions": {
          "completeness": {
            "score": 1.0,
            "reason": "5/5 sections present"
          },
          "evidence_support": {
            "score": 1.0,
            "reason": "4/4 claims have paper evidence"
          },
          "citation_validity": {
            "score": 0.375,
            "reason": "1 verified, 1 partial out of 4"
          },
          "mechanistic_specificity": {
            "score": 0.5,
            "reason": "2/4 claims reference targets"
          },
          "contradiction_handling": {
            "score": 0.3,
            "reason": "No contradiction analysis"
          },
          "traceability": {
            "score": 1.0,
            "reason": "4/4 claims have provenance"
          },
          "output_structure": {
            "score": 1.0,
            "reason": "Executive summary + confidence assessment"
          },
          "actionability": {
            "score": 1.0,
            "reason": "3 next steps, 2 data gaps identified"
          }
        },
        "weak_dimensions": [
          "citation_validity",
          "contradiction_handling"
        ],
        "rerun_targets": []
      }
    },
    "8_risk_flags_limitations": {
      "risk_flags": [
        "Cisplatin has known toxicities (cardiac and renal dysfunction mentioned in PMID: 38418117).",
        "All evidence verification failed",
        "Cisplatin resistance is a significant challenge."
      ],
      "limitations": [
        "The provided literature primarily focuses on mechanisms of resistance and strategies to overcome it, rather than initial repurposing of cisplatin, which is already in use.",
        "Some papers discuss alternative treatments when cisplatin is not tolerated (PMID: 38418117)."
      ],
      "missing_data": [
        "Randomized controlled trials specifically evaluating cisplatin for esophageal cancer (though it's a standard of care, the abstract notes lack of RCTs for CF therapy).",
        "Direct clinical trial data on repurposing cisplatin for esophageal cancer, as it is already a standard treatment."
      ]
    },
    "9_recommended_next_steps": {
      "clinical_next_steps": [
        "Investigate combination therapies to overcome cisplatin resistance.",
        "Explore the role of specific miRNAs (e.g., miR-135b-5p, miR-181a-5p, miR-30a) in modulating cisplatin response.",
        "Evaluate FAM111B and GSDMA as potential therapeutic targets in cisplatin-resistant esophageal cancer."
      ]
    },
    "10_claim_evidence_table": {
      "total_claims": 4,
      "claims": [
        {
          "claim_id": "CLM-48381f",
          "statement": "Cisplatin is a standard treatment for advanced esophageal cancer, but resistance is a major issue.",
          "confidence_numeric": 0.9,
          "confidence_label": "HIGH",
          "polarity": "INCONCLUSIVE",
          "verification_status": "VERIFIED",
          "targets": [],
          "citation_count": 6,
          "risk_flags": []
        },
        {
          "claim_id": "CLM-62f615",
          "statement": "Dysregulation of specific miRNAs contributes to cisplatin resistance in esophageal cancer.",
          "confidence_numeric": 0.8,
          "confidence_label": "HIGH",
          "polarity": "INCONCLUSIVE",
          "verification_status": "PARTIALLY_VERIFIED",
          "targets": [],
          "citation_count": 4,
          "risk_flags": []
        },
        {
          "claim_id": "CLM-7d4d5a",
          "statement": "FAM111B promotes esophageal cancer tumorigenesis and cisplatin resistance by degrading GSDMA.",
          "confidence_numeric": 0.14,
          "confidence_label": "LOW",
          "polarity": "INCONCLUSIVE",
          "verification_status": "UNVERIFIED",
          "targets": [
            "FAM111B",
            "GSDMA"
          ],
          "citation_count": 1,
          "risk_flags": [
            "All evidence verification failed"
          ]
        },
        {
          "claim_id": "CLM-1e516f",
          "statement": "Cordycepin enhances cisplatin sensitivity in esophageal cancer by activating AMPK and suppressing AKT signaling.",
          "confidence_numeric": 0.16,
          "confidence_label": "LOW",
          "polarity": "INCONCLUSIVE",
          "verification_status": "UNVERIFIED",
          "targets": [
            "AMPK",
            "AKT"
          ],
          "citation_count": 1,
          "risk_flags": [
            "All evidence verification failed"
          ]
        }
      ]
    },
    "11_provenance_appendix": {
      "total_entries": 4,
      "entries": [
        {
          "claim_id": "CLM-48381f",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "0cf158dc24b4",
          "timestamp": "2026-06-03T11:45:01.596612+00:00",
          "paper_evidence": [
            {
              "pmid": "38494800",
              "snippet": "CF(cisplatin plus 5-FU)therapy and taxanes( paclitaxel or docetaxel)were considered standard treatments for first- and second-line treatment of advanced esophageal carcinoma based on the results of ph",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "36995552",
              "snippet": "Resistance to cisplatin, one of the majorly used chemotherapeutic drugs in EC, is a major nuisance.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "37672204",
              "snippet": "Chemotherapeutic agents such as cisplatin are commonly used in patients with clinically unresectable or recurrent esophageal cancer (ESCA).",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "37401860",
              "snippet": "Cisplatin (CDDP) is a conventional chemotherapy drug. However, the acquired cisplatin resistance limits its extensively clinical applications.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "38251697",
              "snippet": "Providing insights into the chemoresistance of esophageal squamous cell carcinoma (ESCC) and its dependence on chemotherapy-induced autophagy.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "33067427",
              "snippet": "Although cisplatin (cDDP), is a first-line chemotherapy drug for esophageal cancer, it still has the potential to develop drug resistance and side effects.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 9
        },
        {
          "claim_id": "CLM-62f615",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "0cf158dc24b4",
          "timestamp": "2026-06-03T11:45:01.596612+00:00",
          "paper_evidence": [
            {
              "pmid": "36995552",
              "snippet": "This study sheds light on miRNA dysregulation and its inverse relation with dysregulated mRNAs to guide pathways into the manifestation of cisplatin resistance in EC.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "34277424",
              "snippet": "Our research aimed to reveal the function and mechanism of miR-135b-5p. Our research identified that miR-135b-5p was elevated in EC samples from TCGA database.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "37401860",
              "snippet": "LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.",
              "polarity": "SUPPORTS",
              "verification": "UNVERIFIED",
              "error": "Quote mismatch (fuzzy check failed)"
            },
            {
              "pmid": "38251697",
              "snippet": "The objective of this study is to investigate the modulation of microRNA-30a (miR-30a), a known regulator of autophagy, in ESCC cells by all-trans retinoic acid (ATRA).",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 9
        },
        {
          "claim_id": "CLM-7d4d5a",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "0cf158dc24b4",
          "timestamp": "2026-06-03T11:45:01.596612+00:00",
          "paper_evidence": [
            {
              "pmid": "37672204",
              "snippet": "Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance.",
              "polarity": "SUPPORTS",
              "verification": "UNVERIFIED",
              "error": "Quote mismatch (fuzzy check failed)"
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 9
        },
        {
          "claim_id": "CLM-1e516f",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "0cf158dc24b4",
          "timestamp": "2026-06-03T11:45:01.596612+00:00",
          "paper_evidence": [
            {
              "pmid": "33067427",
              "snippet": "Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.",
              "polarity": "SUPPORTS",
              "verification": "UNVERIFIED",
              "error": "Quote mismatch (fuzzy check failed)"
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 9
        }
      ]
    }
  },
  "metadata": {
    "run_id": "0cf158dc24b4",
    "created_at": "2026-06-03T11:44:38.259994+00:00",
    "drug": "CISPLATIN",
    "disease": "esophageal cancer",
    "total_claims": 4,
    "quality_score": 0.771875,
    "reruns": 0
  }
}
```
